Jasper Therapeutics Gross Profit

Jasper Therapeutics (JSPR) currently reports a gross profit of $0 as of June 2026. That compares with $330K in the prior-year period — down 100.0% year over year. That is below the sector sector average of $720M. Use the charts on this page to explore Jasper Therapeutics's gross profit history and peer comparisons.

Jasper Therapeutics's gross profit decreased from $330K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Jasper Therapeutics's gross profit of $0 is lower than the its sector sector average of $720M. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Jasper Therapeutics reported $0 in gross profit as of June 2026. That compares with $330K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $720M. From there, open related valuation or income-statement pages for Jasper Therapeutics, and consider following JSPR for alerts when major investors trade the stock.